Pravastatin was not better than usual care in reducing all cause mortality or CHD events
نویسندگان
چکیده
منابع مشابه
Pravastatin was not better than usual care in reducing all-cause mortality or CHD events.
and commentary also appear in ACP Journal Club 106 Volume 8 July/August 2003 EBM Therapeutics www.evidence-basedmedicine.com group.bmj.com on December 18, 2017 Published by http://ebm.bmj.com/ Downloaded from
متن کاملAmlodipine or lisinopril was not better than chlorthalidone in lowering CHD risk in hypertension.
Although not mentioned by Dr. Psaty in his commentary (1), concerns have been raised over the heart failure results in ALLHAT (2). Asymptomatic left ventricular (LV) systolic dysfunction is common in older patients, particularly men and patients with cardiovascular risk factors (3, 4). ALLHAT participants were high-risk patients, and many may have had asymptomatic LV dysfunction that could have...
متن کاملReview: early tracheostomy is not better than late tracheostomy for reducing all-cause mortality in critically ill patients.
M e t h o d s Data sources: MEDLINE, CINAHL, EMBASE/Excerpta Medica, Cochrane Central Register of Clinical Trials, National Research Register, the National Health Service Trusts Clinical Trials Register, Medical Research Council U.K. database, National Health Service Research and Development Health Technology Assessment Programme, and British Heart Foundation database (last search in November 2...
متن کاملMultisensory stimulation was not better than usual activities for changing cognition, behaviour, and mood in dementia.
Interventions: eight 30 minute sessions of either MSS (n = 65) or activity (n = 71) twice a week for 4 weeks. Sessions occurred one on one with the same key worker (nurse, occupational therapist, or psychology assistant) whenever possible. MSS was matched to the patient’s needs and interests and included light and sound effects and materials for touching and smelling. The comparison activity se...
متن کاملAmlodipine or lisinopril was not better than chlorthalidone for reducing CVD risk in hypertensive black or nonblack patients.
In black or nonblack patients with hyperten-sion, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD)? Design: Randomized controlled trial (Anti-hypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial [ALLHAT]). Patients: 33 357 black and nonblack patients ≥ 55 years of age (mean age 67 y, 35% black, 53% men overall, 54% women among b...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Evidence-Based Medicine
سال: 2003
ISSN: 1356-5524
DOI: 10.1136/ebm.8.4.106